Thermo Fisher Scientific to acquire Qiagen for $11.5 billion

Thermo Fisher Scientific announced a proposal to acquire Qiagen for €39 per share in cash, valuing the transaction at approximately $11.5 billion including assumed debt.

“Thermo Fisher Scientific, Waltham, Mass, a world leader in serving science, and Qiagen, Venlo, the Netherlands, a leading global provider of molecular diagnostics and sample preparation technologies, today announced that their boards of directors, as well as the managing board of Qiagen, have unanim”clpmag.com

• 1 source
• clpmag.comThermo Fisher ScientificSteve HalaseyMar 3, 2020

Summarized from public sources; check the original articles before acting on it.